A group of 53 biotech leaders are expressing their support for mifepristone in a letter to the Food and Drug Administration, ...

HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone​," but experts say concerns ...

Food and Drug Administration (FDA) Commissioner Marty Makary committed to reviewing the abortion drug mifepristone in a letter sent to Sen. Josh Hawley (R-Mo.). “As with all drugs, FDA continues … ...

The attorneys general of New York, California, Massachusetts and New Jersey asked the FDA to lift some requirements on mifepristone given its “25-year safety record.” June 5, 2025 5 min Summary ...

For those unfamiliar with the medication, the FDA approved mifepristone about a quarter of a century ago, to be used as part of a two-step process to terminate unwanted pregnancies up to 10 weeks.

Over the years, the FDA has removed some restrictions on mifepristone. In 2016, it extended its use from seven to 10 weeks into pregnancy. In 2019, it approved a generic version of the medication.

FDA Commissioner Marty Makary wrote a letter to pro-life Senator Josh Hawley (R., Mo.) Monday informing him of the agency’s plan to conduct a review of mifepristone.

Mifepristone has been used along with another drug — misoprostol — to end early pregnancies in about 7.5 million women since it was approved by the FDA in 2000. About 57% of abortions in New ...